Charlotte Bakker

4PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 22, 2025
Secondary malignancy of T-cell origin after CAR T-cell therapy: EMA's conclusions from the evaluation of 38 suspected cases.

Philipp Berg, Charlotte Bakker, Moritz Sander

|Jun 24, 2021
Safety and Pharmacokinetics of HTL0018318, a Novel M1 Receptor Agonist, Given in Combination with Donepezil at Steady State: A Randomized Trial in Healthy Elderly Subjects.

Charlotte Bakker, Jasper van der Aart, Geert Labots

|Apr 23, 2021
Safety, pharmacokinetics and pharmacodynamics of HTL0009936, a selective muscarinic M1 -acetylcholine receptor agonist: A randomized cross-over trial.

Charlotte Bakker, Samantha Prins, Jan Liptrot

|Dec 22, 2020
First-in-man study to investigate safety, pharmacokinetics and exploratory pharmacodynamics of HTL0018318, a novel M1 -receptor partial agonist for the treatment of dementias.

Charlotte Bakker, Tim Tasker, Jan Liptrot

Pageof 1

Frequent Collaborators

1 joint publications

Jasper Stevens

1 joint publications

Philipp Berg

1 joint publications

Karin Erneholm